We regularly assess the likelihood
of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.
Let us say that you reckon there is a 20 % chance
of an adverse outcome; that is like saying you will be proven wrong one in every five times.
Explain that if they plan birth at home there is a small increase in the risk
of an adverse outcome for the baby.
Dr. Fisher believes that dispassionate, rigorous study of birth across all settings is more important than ever given disparities in women's access to trained and licensed care providers, current and future physician workforce issues, rising costs of health care, and unacceptably high rates
of adverse outcomes for mothers and infants in the U.S. compared to other industrialized countries.
Regulating it, using better trained practitioners and proper guidelines for risking - out and transfer definitely would reduce the rate
of adverse outcomes.
It is essential to note that these significantly increased risks
of adverse outcomes from the setting of home and from the setting of free - standing birth centers reported here may be serious underestimations of clinical complications.
The tradeoff between the additional physical safety conferred by a hospital setting in the case
of an adverse outcome, and the emotional comfort of being in a familiar environment, is sufficient for her.
In many previous U.S. studies, it was not possible to disaggregate planned in - hospital births from planned out - of - hospital births that took place in the hospital after a woman's intrapartum transfer to the hospital.3, 9,10 The latter births represent 16.5 % of planned out - of - hospital births in our population, and misclassification of these births as in - hospital births caused rates
of adverse outcomes among planned out - of - hospital births to be underestimated (in some cases, substantially).
CONCLUSIONS: Our study suggests that high folate intake may have adverse effects on fetal mouse development and that maternal MTHFR deficiency may improve or rescue
some of the adverse outcomes.
Did they provide you with the relative rates
of adverse outcomes in home vs. hospital?
Additional potential benefits are increased patient satisfaction, improved maternal / child well - being and reduced incidence
of adverse outcomes including cesarean sections.
The rates
of some adverse outcomes were too low for us to draw statistical comparisons, and ongoing evaluation of home birth is warranted.
«When one considers the modest decrease in risk
of adverse outcomes associated with the use of a number of widely used medications such as anti-cholesterol drugs, the effect sizes seen in this study are really impressive,» said Dr. Memtsoudis.
«After careful examination of the burden of disease among women aged 40 to 54 years, the guideline development group (GDG) concluded that the lesser, but not insignificant, burden of disease for women aged 40 to 44 years and the higher cumulative risk
of adverse outcomes no longer warranted a direct recommendation to begin screening at age 40 years.»
In the article, Stamatina Iliodromiti from the University of Glasgow, UK, and colleagues found birth weight less than 25th or greater than 85th centile to be associated with greater risk
of adverse outcomes compared with birth weight within these cutoffs, suggesting an expansion of the definition of «fetus at risk» beyond the less than 10th or greater than 90th centile range that is commonly used to trigger surveillance of fetal well - being and / or delivery.
In a new study, a hospital surveillance program focusing on reducing the risks of sepsis, known as the two - stage Clinical Decision Support (CDS) system, was found to reduce the risk
of adverse outcomes, such as death and hospice discharge for sepsis patients, by 30 % over the course of one year.
Professor Heal said there was no difference in the rates
of adverse outcomes (skin irritation, etc) in either group.
The hospital's early recognition and treatment of sepsis resulted in a 30 % reduced risk
of adverse outcomes for sepsis and severe sepsis patients, such as death or discharge to hospice.
«Yet mothers exposed to extreme levels of pesticides, defined here as the top 5 percent of the pesticide exposure distribution, experienced between 5 and 9 percent increases in the probability
of adverse outcomes with an approximately 13 - gram decrease in birth weight.»
At least one
of these adverse outcomes occurred in the year after discharge in 46.3 percent of the highest - risk hospitalizations.
Both one and two year rates
of adverse outcomes compared favorably with historical performance criteria established among medically managed patients with aortic stenosis.
«Together, these findings raise the possibility that hippocampal dysfunction in GWI is one
of the adverse outcomes of persistently elevated oxidative stress and inflammation at the systemic level,» he added.
Predictors
of adverse outcome in adolescents and adults with isolated left ventricular noncompaction
After adjusting for variables which could impact the outcomes, such as age, sex, intensity of depression, and other conditions in addition to use of other medicines, the researchers determined that SSRIs and medications in the group of other medications for depression were linked to a greater risk of a number
of adverse outcomes in contrast to TCAs.
According to new research published in the Journal of Clinical Endocrinology and Metabolism, the current policy of limiting thyroid tests to women at high risk of thyroid disease overlooks most cases of thyroid disease during pregnancy, and undiagnosed, untreated thyroid disease in pregnancy carries a significant risk
of an adverse outcome for both mother and baby.
Clients that have accounts to trade in the speculative instrument are not covered by any compensation and can not complain to the Financial Ombudsman Service or the Financial Services Compensation Scheme in case
of an adverse outcome.
The use of this type of equipment can lead to a variety
of adverse outcomes, including an increased risk of physical injuries, as well as behavioral issues.
The scammers claim that continued human - caused carbon dioxide (CO2) emissions will result in a wide variety
of adverse outcomes if the US does not meet their demands.
As has been commonly the case, denialists are displaying a near - total incapacity to estimate probabilities
of adverse outcomes...
Kennedys partner Mark Burton said: «The enormous increase in claims costs caused by the new rate risks a number
of adverse outcomes.
Many
of the adverse outcomes of having a traffic citation may be prevented by using a state authorized Point Reduction course course.
Of note, this finding differs from the result of previously published results for other types
of adverse outcomes that make use of this cohort and the hierarchical classification of timing of alcohol diagnosis.
Only 87 (37.5 %) were free
of these adverse outcomes.
Approximately 37 % of all children live in poverty for some period during their childhood.16 Children who are born into poverty and live persistently in poor conditions are at greatest risk
of adverse outcomes.
Despite the link that has been reported widely in the literature between poor vision and quality of life outcomes, older adults are not uniform in their experience
of adverse outcomes associated with poor vision.
We chose to use characteristics used for sample recruitment as indicators of long - term stress (eg, coming from a low - SES household) and having few personal resources (eg, being unmarried), 2 factors associated with a host
of adverse outcomes.
Child and youth emotional trauma: An explanatory model
of adverse outcomes.
The average number
of adverse outcomes that women thought could be increased by smoking was 9.2 of the 12 presented.
They could not identify the precise mechanism
of the adverse outcomes, but they did find causal effect between father absence and social - emotional development.
Examples of risk factors that have been found to be associated with depression included partner conflict, single - parenthood, low education and stressful life events [44, 45, 46], which have all, in turn, been related to greater risk
of adverse outcomes in children [47, 48, 49].
We analyzed all children born in Sweden between 1983 and 2009 to investigate the effect of SDP on multiple indicators
of adverse outcomes in three areas: pregnancy outcomes (birth weight, preterm birth and being born small for gestational age), long - term cognitive abilities (low academic achievement and general cognitive ability) and externalizing behaviors (criminal conviction, violent criminal conviction and drug misuse).
It is vital to consider the role of treatment of ADHD in decreasing the individual's risk
of adverse outcomes.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any
adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any
adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the
outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses,
adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include, among others: the unfavorable
outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any
of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components
of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence
of efficacy and adequacy
of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results
of our clinical development activities may not be positive, or predictive
of real - world results or
of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make
adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights
of third parties, or have unintended side effects,
adverse reactions or incidents
of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
«The complexity
of this deal and the measurement
of the
outcomes makes this event challenging and we fear disruption, in the interim, could have an
adverse impact on business,» he writes.
My conclusion is that the easing
of financial conditions resulting from non-traditional policy actions has had a material effect on both nominal and real growth and has demonstrably reduced the risk
of particularly
adverse outcomes.
(The
outcome of the
adverse feedback.)
One must ask then how it is that if Protestant leaders in higher education generally made the right — or at least virtually inevitable — decisions, what has gone wrong that the
outcome should be so
adverse to the apparent interests
of Protestant Christianity?
«
Of the millions of animals exported under ESCAS there have been 22 identified incidents of non-compliance where the animal welfare outcome was either adverse or unknow
Of the millions
of animals exported under ESCAS there have been 22 identified incidents of non-compliance where the animal welfare outcome was either adverse or unknow
of animals exported under ESCAS there have been 22 identified incidents
of non-compliance where the animal welfare outcome was either adverse or unknow
of non-compliance where the animal welfare
outcome was either
adverse or unknown.
«The Australian beverages industry is responsive to the health and dietary requirements
of Australians but isolating any food or beverage as the sole contributor in any
adverse health
outcome overlooks many other factors that need to be considered such as health, diet and lifestyle,» the Australian Beverages Council CEO Geoff Parker said.